Pharma & Healthcare
Global Sevoflurane (Sevoflurane Source) Market Research Report 2025
- Apr 16, 25
- ID: 196016
- Pages: 84
- Figures: 84
- Views: 1
The global market for Sevoflurane (Sevoflurane Source) was valued at US$ 1195 million in the year 2024 and is projected to reach a revised size of US$ 1527 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sevoflurane (Sevoflurane Source), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sevoflurane (Sevoflurane Source).
The Sevoflurane (Sevoflurane Source) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sevoflurane (Sevoflurane Source) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sevoflurane (Sevoflurane Source) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Hengrui
Baxter
Maruishi
AbbVie
Piramal
Viatris
PT Novell Pharmaceutical
Lunan Pharma
Segment by Type
Original Drugs
Generic Drugs
Segment by Application
Hospital
Clinics
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sevoflurane (Sevoflurane Source) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sevoflurane (Sevoflurane Source) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sevoflurane (Sevoflurane Source), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sevoflurane (Sevoflurane Source).
The Sevoflurane (Sevoflurane Source) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sevoflurane (Sevoflurane Source) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sevoflurane (Sevoflurane Source) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Hengrui
Baxter
Maruishi
AbbVie
Piramal
Viatris
PT Novell Pharmaceutical
Lunan Pharma
Segment by Type
Original Drugs
Generic Drugs
Segment by Application
Hospital
Clinics
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sevoflurane (Sevoflurane Source) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sevoflurane (Sevoflurane Source) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Sevoflurane (Sevoflurane Source) Market Overview
1.1 Product Definition
1.2 Sevoflurane (Sevoflurane Source) by Type
1.2.1 Global Sevoflurane (Sevoflurane Source) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Sevoflurane (Sevoflurane Source) by Application
1.3.1 Global Sevoflurane (Sevoflurane Source) Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Sevoflurane (Sevoflurane Source) Market Size Estimates and Forecasts
1.4.1 Global Sevoflurane (Sevoflurane Source) Revenue 2020-2031
1.4.2 Global Sevoflurane (Sevoflurane Source) Sales 2020-2031
1.4.3 Global Sevoflurane (Sevoflurane Source) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sevoflurane (Sevoflurane Source) Market Competition by Manufacturers
2.1 Global Sevoflurane (Sevoflurane Source) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sevoflurane (Sevoflurane Source) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sevoflurane (Sevoflurane Source), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sevoflurane (Sevoflurane Source), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sevoflurane (Sevoflurane Source), Product Type & Application
2.7 Global Key Manufacturers of Sevoflurane (Sevoflurane Source), Date of Enter into This Industry
2.8 Global Sevoflurane (Sevoflurane Source) Market Competitive Situation and Trends
2.8.1 Global Sevoflurane (Sevoflurane Source) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sevoflurane (Sevoflurane Source) Players Market Share by Revenue
2.8.3 Global Sevoflurane (Sevoflurane Source) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sevoflurane (Sevoflurane Source) Market Scenario by Region
3.1 Global Sevoflurane (Sevoflurane Source) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sevoflurane (Sevoflurane Source) Sales by Region: 2020-2031
3.2.1 Global Sevoflurane (Sevoflurane Source) Sales by Region: 2020-2025
3.2.2 Global Sevoflurane (Sevoflurane Source) Sales by Region: 2026-2031
3.3 Global Sevoflurane (Sevoflurane Source) Revenue by Region: 2020-2031
3.3.1 Global Sevoflurane (Sevoflurane Source) Revenue by Region: 2020-2025
3.3.2 Global Sevoflurane (Sevoflurane Source) Revenue by Region: 2026-2031
3.4 North America Sevoflurane (Sevoflurane Source) Market Facts & Figures by Country
3.4.1 North America Sevoflurane (Sevoflurane Source) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sevoflurane (Sevoflurane Source) Sales by Country (2020-2031)
3.4.3 North America Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sevoflurane (Sevoflurane Source) Market Facts & Figures by Country
3.5.1 Europe Sevoflurane (Sevoflurane Source) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sevoflurane (Sevoflurane Source) Sales by Country (2020-2031)
3.5.3 Europe Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sevoflurane (Sevoflurane Source) Market Facts & Figures by Region
3.6.1 Asia Pacific Sevoflurane (Sevoflurane Source) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sevoflurane (Sevoflurane Source) Sales by Region (2020-2031)
3.6.3 Asia Pacific Sevoflurane (Sevoflurane Source) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sevoflurane (Sevoflurane Source) Market Facts & Figures by Country
3.7.1 Latin America Sevoflurane (Sevoflurane Source) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sevoflurane (Sevoflurane Source) Sales by Country (2020-2031)
3.7.3 Latin America Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sevoflurane (Sevoflurane Source) Market Facts & Figures by Country
3.8.1 Middle East and Africa Sevoflurane (Sevoflurane Source) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sevoflurane (Sevoflurane Source) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sevoflurane (Sevoflurane Source) Sales by Type (2020-2031)
4.1.1 Global Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
4.1.2 Global Sevoflurane (Sevoflurane Source) Sales by Type (2026-2031)
4.1.3 Global Sevoflurane (Sevoflurane Source) Sales Market Share by Type (2020-2031)
4.2 Global Sevoflurane (Sevoflurane Source) Revenue by Type (2020-2031)
4.2.1 Global Sevoflurane (Sevoflurane Source) Revenue by Type (2020-2025)
4.2.2 Global Sevoflurane (Sevoflurane Source) Revenue by Type (2026-2031)
4.2.3 Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Type (2020-2031)
4.3 Global Sevoflurane (Sevoflurane Source) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sevoflurane (Sevoflurane Source) Sales by Application (2020-2031)
5.1.1 Global Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
5.1.2 Global Sevoflurane (Sevoflurane Source) Sales by Application (2026-2031)
5.1.3 Global Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2031)
5.2 Global Sevoflurane (Sevoflurane Source) Revenue by Application (2020-2031)
5.2.1 Global Sevoflurane (Sevoflurane Source) Revenue by Application (2020-2025)
5.2.2 Global Sevoflurane (Sevoflurane Source) Revenue by Application (2026-2031)
5.2.3 Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Application (2020-2031)
5.3 Global Sevoflurane (Sevoflurane Source) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hengrui
6.1.1 Hengrui Company Information
6.1.2 Hengrui Description and Business Overview
6.1.3 Hengrui Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hengrui Sevoflurane (Sevoflurane Source) Product Portfolio
6.1.5 Hengrui Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter Sevoflurane (Sevoflurane Source) Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Maruishi
6.3.1 Maruishi Company Information
6.3.2 Maruishi Description and Business Overview
6.3.3 Maruishi Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Maruishi Sevoflurane (Sevoflurane Source) Product Portfolio
6.3.5 Maruishi Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Company Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AbbVie Sevoflurane (Sevoflurane Source) Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Piramal
6.5.1 Piramal Company Information
6.5.2 Piramal Description and Business Overview
6.5.3 Piramal Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Piramal Sevoflurane (Sevoflurane Source) Product Portfolio
6.5.5 Piramal Recent Developments/Updates
6.6 Viatris
6.6.1 Viatris Company Information
6.6.2 Viatris Description and Business Overview
6.6.3 Viatris Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Viatris Sevoflurane (Sevoflurane Source) Product Portfolio
6.6.5 Viatris Recent Developments/Updates
6.7 PT Novell Pharmaceutical
6.7.1 PT Novell Pharmaceutical Company Information
6.7.2 PT Novell Pharmaceutical Description and Business Overview
6.7.3 PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Product Portfolio
6.7.5 PT Novell Pharmaceutical Recent Developments/Updates
6.8 Lunan Pharma
6.8.1 Lunan Pharma Company Information
6.8.2 Lunan Pharma Description and Business Overview
6.8.3 Lunan Pharma Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Lunan Pharma Sevoflurane (Sevoflurane Source) Product Portfolio
6.8.5 Lunan Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sevoflurane (Sevoflurane Source) Industry Chain Analysis
7.2 Sevoflurane (Sevoflurane Source) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sevoflurane (Sevoflurane Source) Production Mode & Process Analysis
7.4 Sevoflurane (Sevoflurane Source) Sales and Marketing
7.4.1 Sevoflurane (Sevoflurane Source) Sales Channels
7.4.2 Sevoflurane (Sevoflurane Source) Distributors
7.5 Sevoflurane (Sevoflurane Source) Customer Analysis
8 Sevoflurane (Sevoflurane Source) Market Dynamics
8.1 Sevoflurane (Sevoflurane Source) Industry Trends
8.2 Sevoflurane (Sevoflurane Source) Market Drivers
8.3 Sevoflurane (Sevoflurane Source) Market Challenges
8.4 Sevoflurane (Sevoflurane Source) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Sevoflurane (Sevoflurane Source) by Type
1.2.1 Global Sevoflurane (Sevoflurane Source) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Sevoflurane (Sevoflurane Source) by Application
1.3.1 Global Sevoflurane (Sevoflurane Source) Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Sevoflurane (Sevoflurane Source) Market Size Estimates and Forecasts
1.4.1 Global Sevoflurane (Sevoflurane Source) Revenue 2020-2031
1.4.2 Global Sevoflurane (Sevoflurane Source) Sales 2020-2031
1.4.3 Global Sevoflurane (Sevoflurane Source) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sevoflurane (Sevoflurane Source) Market Competition by Manufacturers
2.1 Global Sevoflurane (Sevoflurane Source) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sevoflurane (Sevoflurane Source) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sevoflurane (Sevoflurane Source), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sevoflurane (Sevoflurane Source), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sevoflurane (Sevoflurane Source), Product Type & Application
2.7 Global Key Manufacturers of Sevoflurane (Sevoflurane Source), Date of Enter into This Industry
2.8 Global Sevoflurane (Sevoflurane Source) Market Competitive Situation and Trends
2.8.1 Global Sevoflurane (Sevoflurane Source) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sevoflurane (Sevoflurane Source) Players Market Share by Revenue
2.8.3 Global Sevoflurane (Sevoflurane Source) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sevoflurane (Sevoflurane Source) Market Scenario by Region
3.1 Global Sevoflurane (Sevoflurane Source) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sevoflurane (Sevoflurane Source) Sales by Region: 2020-2031
3.2.1 Global Sevoflurane (Sevoflurane Source) Sales by Region: 2020-2025
3.2.2 Global Sevoflurane (Sevoflurane Source) Sales by Region: 2026-2031
3.3 Global Sevoflurane (Sevoflurane Source) Revenue by Region: 2020-2031
3.3.1 Global Sevoflurane (Sevoflurane Source) Revenue by Region: 2020-2025
3.3.2 Global Sevoflurane (Sevoflurane Source) Revenue by Region: 2026-2031
3.4 North America Sevoflurane (Sevoflurane Source) Market Facts & Figures by Country
3.4.1 North America Sevoflurane (Sevoflurane Source) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sevoflurane (Sevoflurane Source) Sales by Country (2020-2031)
3.4.3 North America Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sevoflurane (Sevoflurane Source) Market Facts & Figures by Country
3.5.1 Europe Sevoflurane (Sevoflurane Source) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sevoflurane (Sevoflurane Source) Sales by Country (2020-2031)
3.5.3 Europe Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sevoflurane (Sevoflurane Source) Market Facts & Figures by Region
3.6.1 Asia Pacific Sevoflurane (Sevoflurane Source) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sevoflurane (Sevoflurane Source) Sales by Region (2020-2031)
3.6.3 Asia Pacific Sevoflurane (Sevoflurane Source) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sevoflurane (Sevoflurane Source) Market Facts & Figures by Country
3.7.1 Latin America Sevoflurane (Sevoflurane Source) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sevoflurane (Sevoflurane Source) Sales by Country (2020-2031)
3.7.3 Latin America Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sevoflurane (Sevoflurane Source) Market Facts & Figures by Country
3.8.1 Middle East and Africa Sevoflurane (Sevoflurane Source) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sevoflurane (Sevoflurane Source) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sevoflurane (Sevoflurane Source) Sales by Type (2020-2031)
4.1.1 Global Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
4.1.2 Global Sevoflurane (Sevoflurane Source) Sales by Type (2026-2031)
4.1.3 Global Sevoflurane (Sevoflurane Source) Sales Market Share by Type (2020-2031)
4.2 Global Sevoflurane (Sevoflurane Source) Revenue by Type (2020-2031)
4.2.1 Global Sevoflurane (Sevoflurane Source) Revenue by Type (2020-2025)
4.2.2 Global Sevoflurane (Sevoflurane Source) Revenue by Type (2026-2031)
4.2.3 Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Type (2020-2031)
4.3 Global Sevoflurane (Sevoflurane Source) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sevoflurane (Sevoflurane Source) Sales by Application (2020-2031)
5.1.1 Global Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
5.1.2 Global Sevoflurane (Sevoflurane Source) Sales by Application (2026-2031)
5.1.3 Global Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2031)
5.2 Global Sevoflurane (Sevoflurane Source) Revenue by Application (2020-2031)
5.2.1 Global Sevoflurane (Sevoflurane Source) Revenue by Application (2020-2025)
5.2.2 Global Sevoflurane (Sevoflurane Source) Revenue by Application (2026-2031)
5.2.3 Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Application (2020-2031)
5.3 Global Sevoflurane (Sevoflurane Source) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hengrui
6.1.1 Hengrui Company Information
6.1.2 Hengrui Description and Business Overview
6.1.3 Hengrui Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hengrui Sevoflurane (Sevoflurane Source) Product Portfolio
6.1.5 Hengrui Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter Sevoflurane (Sevoflurane Source) Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Maruishi
6.3.1 Maruishi Company Information
6.3.2 Maruishi Description and Business Overview
6.3.3 Maruishi Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Maruishi Sevoflurane (Sevoflurane Source) Product Portfolio
6.3.5 Maruishi Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Company Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AbbVie Sevoflurane (Sevoflurane Source) Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Piramal
6.5.1 Piramal Company Information
6.5.2 Piramal Description and Business Overview
6.5.3 Piramal Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Piramal Sevoflurane (Sevoflurane Source) Product Portfolio
6.5.5 Piramal Recent Developments/Updates
6.6 Viatris
6.6.1 Viatris Company Information
6.6.2 Viatris Description and Business Overview
6.6.3 Viatris Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Viatris Sevoflurane (Sevoflurane Source) Product Portfolio
6.6.5 Viatris Recent Developments/Updates
6.7 PT Novell Pharmaceutical
6.7.1 PT Novell Pharmaceutical Company Information
6.7.2 PT Novell Pharmaceutical Description and Business Overview
6.7.3 PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Product Portfolio
6.7.5 PT Novell Pharmaceutical Recent Developments/Updates
6.8 Lunan Pharma
6.8.1 Lunan Pharma Company Information
6.8.2 Lunan Pharma Description and Business Overview
6.8.3 Lunan Pharma Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Lunan Pharma Sevoflurane (Sevoflurane Source) Product Portfolio
6.8.5 Lunan Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sevoflurane (Sevoflurane Source) Industry Chain Analysis
7.2 Sevoflurane (Sevoflurane Source) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sevoflurane (Sevoflurane Source) Production Mode & Process Analysis
7.4 Sevoflurane (Sevoflurane Source) Sales and Marketing
7.4.1 Sevoflurane (Sevoflurane Source) Sales Channels
7.4.2 Sevoflurane (Sevoflurane Source) Distributors
7.5 Sevoflurane (Sevoflurane Source) Customer Analysis
8 Sevoflurane (Sevoflurane Source) Market Dynamics
8.1 Sevoflurane (Sevoflurane Source) Industry Trends
8.2 Sevoflurane (Sevoflurane Source) Market Drivers
8.3 Sevoflurane (Sevoflurane Source) Market Challenges
8.4 Sevoflurane (Sevoflurane Source) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Sevoflurane (Sevoflurane Source) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Sevoflurane (Sevoflurane Source) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Sevoflurane (Sevoflurane Source) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Sevoflurane (Sevoflurane Source) Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Sevoflurane (Sevoflurane Source) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Sevoflurane (Sevoflurane Source) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Sevoflurane (Sevoflurane Source) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Sevoflurane (Sevoflurane Source), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sevoflurane (Sevoflurane Source), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sevoflurane (Sevoflurane Source), Product Type & Application
Table 12. Global Key Manufacturers of Sevoflurane (Sevoflurane Source), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sevoflurane (Sevoflurane Source) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane (Sevoflurane Source) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sevoflurane (Sevoflurane Source) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Sevoflurane (Sevoflurane Source) Sales by Region (2020-2025) & (K Units)
Table 18. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Region (2020-2025)
Table 19. Global Sevoflurane (Sevoflurane Source) Sales by Region (2026-2031) & (K Units)
Table 20. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Region (2026-2031)
Table 21. Global Sevoflurane (Sevoflurane Source) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Region (2020-2025)
Table 23. Global Sevoflurane (Sevoflurane Source) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Region (2026-2031)
Table 25. North America Sevoflurane (Sevoflurane Source) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
Table 27. North America Sevoflurane (Sevoflurane Source) Sales by Country (2026-2031) & (K Units)
Table 28. North America Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Sevoflurane (Sevoflurane Source) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Sevoflurane (Sevoflurane Source) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
Table 32. Europe Sevoflurane (Sevoflurane Source) Sales by Country (2026-2031) & (K Units)
Table 33. Europe Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Sevoflurane (Sevoflurane Source) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Sevoflurane (Sevoflurane Source) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Sevoflurane (Sevoflurane Source) Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Sevoflurane (Sevoflurane Source) Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Sevoflurane (Sevoflurane Source) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Sevoflurane (Sevoflurane Source) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Sevoflurane (Sevoflurane Source) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Sevoflurane (Sevoflurane Source) Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Sevoflurane (Sevoflurane Source) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Sevoflurane (Sevoflurane Source) Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Sevoflurane (Sevoflurane Source) Sales (K Units) by Type (2020-2025)
Table 51. Global Sevoflurane (Sevoflurane Source) Sales (K Units) by Type (2026-2031)
Table 52. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Type (2020-2025)
Table 53. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Type (2026-2031)
Table 54. Global Sevoflurane (Sevoflurane Source) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Sevoflurane (Sevoflurane Source) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Type (2020-2025)
Table 57. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Type (2026-2031)
Table 58. Global Sevoflurane (Sevoflurane Source) Price (US$/Unit) by Type (2020-2025)
Table 59. Global Sevoflurane (Sevoflurane Source) Price (US$/Unit) by Type (2026-2031)
Table 60. Global Sevoflurane (Sevoflurane Source) Sales (K Units) by Application (2020-2025)
Table 61. Global Sevoflurane (Sevoflurane Source) Sales (K Units) by Application (2026-2031)
Table 62. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
Table 63. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2026-2031)
Table 64. Global Sevoflurane (Sevoflurane Source) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Sevoflurane (Sevoflurane Source) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Application (2020-2025)
Table 67. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Application (2026-2031)
Table 68. Global Sevoflurane (Sevoflurane Source) Price (US$/Unit) by Application (2020-2025)
Table 69. Global Sevoflurane (Sevoflurane Source) Price (US$/Unit) by Application (2026-2031)
Table 70. Hengrui Company Information
Table 71. Hengrui Description and Business Overview
Table 72. Hengrui Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Hengrui Sevoflurane (Sevoflurane Source) Product
Table 74. Hengrui Recent Developments/Updates
Table 75. Baxter Company Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Baxter Sevoflurane (Sevoflurane Source) Product
Table 79. Baxter Recent Developments/Updates
Table 80. Maruishi Company Information
Table 81. Maruishi Description and Business Overview
Table 82. Maruishi Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Maruishi Sevoflurane (Sevoflurane Source) Product
Table 84. Maruishi Recent Developments/Updates
Table 85. AbbVie Company Information
Table 86. AbbVie Description and Business Overview
Table 87. AbbVie Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AbbVie Sevoflurane (Sevoflurane Source) Product
Table 89. AbbVie Recent Developments/Updates
Table 90. Piramal Company Information
Table 91. Piramal Description and Business Overview
Table 92. Piramal Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Piramal Sevoflurane (Sevoflurane Source) Product
Table 94. Piramal Recent Developments/Updates
Table 95. Viatris Company Information
Table 96. Viatris Description and Business Overview
Table 97. Viatris Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Viatris Sevoflurane (Sevoflurane Source) Product
Table 99. Viatris Recent Developments/Updates
Table 100. PT Novell Pharmaceutical Company Information
Table 101. PT Novell Pharmaceutical Description and Business Overview
Table 102. PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Product
Table 104. PT Novell Pharmaceutical Recent Developments/Updates
Table 105. Lunan Pharma Company Information
Table 106. Lunan Pharma Description and Business Overview
Table 107. Lunan Pharma Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Lunan Pharma Sevoflurane (Sevoflurane Source) Product
Table 109. Lunan Pharma Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Sevoflurane (Sevoflurane Source) Distributors List
Table 113. Sevoflurane (Sevoflurane Source) Customers List
Table 114. Sevoflurane (Sevoflurane Source) Market Trends
Table 115. Sevoflurane (Sevoflurane Source) Market Drivers
Table 116. Sevoflurane (Sevoflurane Source) Market Challenges
Table 117. Sevoflurane (Sevoflurane Source) Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Sevoflurane (Sevoflurane Source)
Figure 2. Global Sevoflurane (Sevoflurane Source) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sevoflurane (Sevoflurane Source) Market Share by Type: 2024 & 2031
Figure 4. Original Drugs Product Picture
Figure 5. Generic Drugs Product Picture
Figure 6. Global Sevoflurane (Sevoflurane Source) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Sevoflurane (Sevoflurane Source) Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinics
Figure 10. Other
Figure 11. Global Sevoflurane (Sevoflurane Source) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Sevoflurane (Sevoflurane Source) Market Size (2020-2031) & (US$ Million)
Figure 13. Global Sevoflurane (Sevoflurane Source) Sales (2020-2031) & (K Units)
Figure 14. Global Sevoflurane (Sevoflurane Source) Average Price (US$/Unit) & (2020-2031)
Figure 15. Sevoflurane (Sevoflurane Source) Report Years Considered
Figure 16. Sevoflurane (Sevoflurane Source) Sales Share by Manufacturers in 2024
Figure 17. Global Sevoflurane (Sevoflurane Source) Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Sevoflurane (Sevoflurane Source) Players: Market Share by Revenue in Sevoflurane (Sevoflurane Source) in 2024
Figure 19. Sevoflurane (Sevoflurane Source) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Sevoflurane (Sevoflurane Source) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2031)
Figure 22. North America Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2031)
Figure 26. Europe Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2031)
Figure 27. Germany Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Sevoflurane (Sevoflurane Source) Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Sevoflurane (Sevoflurane Source) Revenue Market Share by Region (2020-2031)
Figure 34. China Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2031)
Figure 45. Latin America Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Sevoflurane (Sevoflurane Source) by Type (2020-2031)
Figure 55. Global Revenue Market Share of Sevoflurane (Sevoflurane Source) by Type (2020-2031)
Figure 56. Global Sevoflurane (Sevoflurane Source) Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Sevoflurane (Sevoflurane Source) by Application (2020-2031)
Figure 58. Global Revenue Market Share of Sevoflurane (Sevoflurane Source) by Application (2020-2031)
Figure 59. Global Sevoflurane (Sevoflurane Source) Price (US$/Unit) by Application (2020-2031)
Figure 60. Sevoflurane (Sevoflurane Source) Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Sevoflurane (Sevoflurane Source) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Sevoflurane (Sevoflurane Source) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Sevoflurane (Sevoflurane Source) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Sevoflurane (Sevoflurane Source) Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Sevoflurane (Sevoflurane Source) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Sevoflurane (Sevoflurane Source) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Sevoflurane (Sevoflurane Source) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Sevoflurane (Sevoflurane Source), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sevoflurane (Sevoflurane Source), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sevoflurane (Sevoflurane Source), Product Type & Application
Table 12. Global Key Manufacturers of Sevoflurane (Sevoflurane Source), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sevoflurane (Sevoflurane Source) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane (Sevoflurane Source) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sevoflurane (Sevoflurane Source) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Sevoflurane (Sevoflurane Source) Sales by Region (2020-2025) & (K Units)
Table 18. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Region (2020-2025)
Table 19. Global Sevoflurane (Sevoflurane Source) Sales by Region (2026-2031) & (K Units)
Table 20. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Region (2026-2031)
Table 21. Global Sevoflurane (Sevoflurane Source) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Region (2020-2025)
Table 23. Global Sevoflurane (Sevoflurane Source) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Region (2026-2031)
Table 25. North America Sevoflurane (Sevoflurane Source) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
Table 27. North America Sevoflurane (Sevoflurane Source) Sales by Country (2026-2031) & (K Units)
Table 28. North America Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Sevoflurane (Sevoflurane Source) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Sevoflurane (Sevoflurane Source) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
Table 32. Europe Sevoflurane (Sevoflurane Source) Sales by Country (2026-2031) & (K Units)
Table 33. Europe Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Sevoflurane (Sevoflurane Source) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Sevoflurane (Sevoflurane Source) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Sevoflurane (Sevoflurane Source) Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Sevoflurane (Sevoflurane Source) Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Sevoflurane (Sevoflurane Source) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Sevoflurane (Sevoflurane Source) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Sevoflurane (Sevoflurane Source) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Sevoflurane (Sevoflurane Source) Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Sevoflurane (Sevoflurane Source) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Sevoflurane (Sevoflurane Source) Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Sevoflurane (Sevoflurane Source) Sales (K Units) by Type (2020-2025)
Table 51. Global Sevoflurane (Sevoflurane Source) Sales (K Units) by Type (2026-2031)
Table 52. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Type (2020-2025)
Table 53. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Type (2026-2031)
Table 54. Global Sevoflurane (Sevoflurane Source) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Sevoflurane (Sevoflurane Source) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Type (2020-2025)
Table 57. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Type (2026-2031)
Table 58. Global Sevoflurane (Sevoflurane Source) Price (US$/Unit) by Type (2020-2025)
Table 59. Global Sevoflurane (Sevoflurane Source) Price (US$/Unit) by Type (2026-2031)
Table 60. Global Sevoflurane (Sevoflurane Source) Sales (K Units) by Application (2020-2025)
Table 61. Global Sevoflurane (Sevoflurane Source) Sales (K Units) by Application (2026-2031)
Table 62. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
Table 63. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2026-2031)
Table 64. Global Sevoflurane (Sevoflurane Source) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Sevoflurane (Sevoflurane Source) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Application (2020-2025)
Table 67. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Application (2026-2031)
Table 68. Global Sevoflurane (Sevoflurane Source) Price (US$/Unit) by Application (2020-2025)
Table 69. Global Sevoflurane (Sevoflurane Source) Price (US$/Unit) by Application (2026-2031)
Table 70. Hengrui Company Information
Table 71. Hengrui Description and Business Overview
Table 72. Hengrui Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Hengrui Sevoflurane (Sevoflurane Source) Product
Table 74. Hengrui Recent Developments/Updates
Table 75. Baxter Company Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Baxter Sevoflurane (Sevoflurane Source) Product
Table 79. Baxter Recent Developments/Updates
Table 80. Maruishi Company Information
Table 81. Maruishi Description and Business Overview
Table 82. Maruishi Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Maruishi Sevoflurane (Sevoflurane Source) Product
Table 84. Maruishi Recent Developments/Updates
Table 85. AbbVie Company Information
Table 86. AbbVie Description and Business Overview
Table 87. AbbVie Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AbbVie Sevoflurane (Sevoflurane Source) Product
Table 89. AbbVie Recent Developments/Updates
Table 90. Piramal Company Information
Table 91. Piramal Description and Business Overview
Table 92. Piramal Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Piramal Sevoflurane (Sevoflurane Source) Product
Table 94. Piramal Recent Developments/Updates
Table 95. Viatris Company Information
Table 96. Viatris Description and Business Overview
Table 97. Viatris Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Viatris Sevoflurane (Sevoflurane Source) Product
Table 99. Viatris Recent Developments/Updates
Table 100. PT Novell Pharmaceutical Company Information
Table 101. PT Novell Pharmaceutical Description and Business Overview
Table 102. PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Product
Table 104. PT Novell Pharmaceutical Recent Developments/Updates
Table 105. Lunan Pharma Company Information
Table 106. Lunan Pharma Description and Business Overview
Table 107. Lunan Pharma Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Lunan Pharma Sevoflurane (Sevoflurane Source) Product
Table 109. Lunan Pharma Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Sevoflurane (Sevoflurane Source) Distributors List
Table 113. Sevoflurane (Sevoflurane Source) Customers List
Table 114. Sevoflurane (Sevoflurane Source) Market Trends
Table 115. Sevoflurane (Sevoflurane Source) Market Drivers
Table 116. Sevoflurane (Sevoflurane Source) Market Challenges
Table 117. Sevoflurane (Sevoflurane Source) Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Sevoflurane (Sevoflurane Source)
Figure 2. Global Sevoflurane (Sevoflurane Source) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sevoflurane (Sevoflurane Source) Market Share by Type: 2024 & 2031
Figure 4. Original Drugs Product Picture
Figure 5. Generic Drugs Product Picture
Figure 6. Global Sevoflurane (Sevoflurane Source) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Sevoflurane (Sevoflurane Source) Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinics
Figure 10. Other
Figure 11. Global Sevoflurane (Sevoflurane Source) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Sevoflurane (Sevoflurane Source) Market Size (2020-2031) & (US$ Million)
Figure 13. Global Sevoflurane (Sevoflurane Source) Sales (2020-2031) & (K Units)
Figure 14. Global Sevoflurane (Sevoflurane Source) Average Price (US$/Unit) & (2020-2031)
Figure 15. Sevoflurane (Sevoflurane Source) Report Years Considered
Figure 16. Sevoflurane (Sevoflurane Source) Sales Share by Manufacturers in 2024
Figure 17. Global Sevoflurane (Sevoflurane Source) Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Sevoflurane (Sevoflurane Source) Players: Market Share by Revenue in Sevoflurane (Sevoflurane Source) in 2024
Figure 19. Sevoflurane (Sevoflurane Source) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Sevoflurane (Sevoflurane Source) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2031)
Figure 22. North America Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2031)
Figure 26. Europe Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2031)
Figure 27. Germany Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Sevoflurane (Sevoflurane Source) Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Sevoflurane (Sevoflurane Source) Revenue Market Share by Region (2020-2031)
Figure 34. China Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2031)
Figure 45. Latin America Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Sevoflurane (Sevoflurane Source) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Sevoflurane (Sevoflurane Source) by Type (2020-2031)
Figure 55. Global Revenue Market Share of Sevoflurane (Sevoflurane Source) by Type (2020-2031)
Figure 56. Global Sevoflurane (Sevoflurane Source) Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Sevoflurane (Sevoflurane Source) by Application (2020-2031)
Figure 58. Global Revenue Market Share of Sevoflurane (Sevoflurane Source) by Application (2020-2031)
Figure 59. Global Sevoflurane (Sevoflurane Source) Price (US$/Unit) by Application (2020-2031)
Figure 60. Sevoflurane (Sevoflurane Source) Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232